BIOMAT Database Logo BIOMAT Database Logo

[Secretory immunity in persons inoculated with killed influenza vaccine purified and concentrated on silicate sorbents]. 1976

M A Bichurina

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007071 Immunoglobulin A, Secretory The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS). Colostral IgA,IgA, Exocrine,IgA, Secretory,SIgA,Secretory IgA,Secretory Immunoglobulin A,Exocrine IgA,IgA, Colostral
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007164 Immunosorbents An insoluble support for an ANTIGEN or ANTIBODIES that is used in AFFINITY CHROMATOGRAPHY to adsorb the homologous antibody or antigen from a mixture. Many different substances are used, among them SEPHAROSE; GLUTARALDEHYDE; copolymers of ANHYDRIDES; polyacrylamides, etc. Immunoadsorbent,Immunoadsorbents,Immunosorbent
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M A Bichurina
[Control of killed influenza vaccine purified and concentrated on silicate sorbents].
January 1976, Trudy Instituta imeni Pastera,
M A Bichurina
[Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silicate sorbents. I. The immunogenic properties of a vaccine from the A/Victoria/72 strain].
January 1976, Trudy Instituta imeni Pastera,
M A Bichurina
[Characteristics of the basic parameters of killed influenza vaccine purified and concentrated on sodium borsilicate glass].
September 1976, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M A Bichurina
THE PRECIPITATION OF PURIFIED CONCENTRATED INFLUENZA VIRUS AND VACCINE ON CALCIUM PHOSPHATE.
March 1945, Science (New York, N.Y.),
M A Bichurina
Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation.
December 2018, Archives of Razi Institute,
M A Bichurina
[Experience in the study of the immunogenicity of killed influenza vaccine, purified and concentrated by the method of sorption chromatography].
January 1973, Trudy Leningradskogo nauchno-issledovatel'skogo instituta epidemiologii i mikrobiologii imeni Pastera,
M A Bichurina
[Formation of immunity in intranasal immunization with live and killed influenza vaccine].
September 1975, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M A Bichurina
[Characteristics of the antitoxic immunity in persons inoculated with chemical typhus vaccine].
March 1982, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M A Bichurina
[Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. I. Laboratory evaluation data].
January 1976, Trudy Instituta imeni Pastera,
M A Bichurina
[Correlation between the frequency of the occurrence of temperature reactions and humoral immunity indices in persons inoculated with a concentrated tick-borne encephalitis vaccine].
January 1983, Voprosy virusologii,
Copied contents to your clipboard!